VERACYTE, INC.·4

Mar 6, 4:32 PM ET

Leite John 4

Research Summary

AI-generated summary

Updated

Veracyte (VCYT) CCO John Leite Sells 5,260 Shares

What Happened John Leite, Chief Commercial Officer (CLIA) of Veracyte, sold 5,260 shares of VCYT stock on March 4, 2026. The weighted average sale price was $35.19, for total proceeds of approximately $185,083. The sale was reported on Form 4 filed March 6, 2026 and is reported as an open‑market/private sale (code S).

Key Details

  • Transaction date: 2026-03-04; Form 4 filed: 2026-03-06 (timely filing).
  • Shares sold: 5,260; weighted average price: $35.19; total proceeds ≈ $185,083.
  • Price range for individual lots: $35.00 to $35.53 (weighted average reported; breakdown available on request per footnote).
  • Sale executed pursuant to a prearranged Rule 10b5‑1 trading plan adopted by Mr. Leite on June 9, 2025 (per footnote).
  • Shares owned after the transaction: not specified in the provided filing.

Context This was a sale under a 10b5‑1 plan, which typically indicates a preplanned, scheduled disposition rather than a spontaneous market signal. Sales are common for insiders for liquidity or diversification and are generally less informative than purchases about insider confidence in the company.